These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6317990)

  • 1. Biochemical termination of sustained fibrillation occurring after artificially induced ischemic arrest.
    Robicsek F
    J Thorac Cardiovasc Surg; 1984 Jan; 87(1):143-5. PubMed ID: 6317990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanoenergetic function and troponin T release following cardioplegic arrest induced by St Thomas' and histidine-tryptophan-ketoglutarate cardioplegia--an experimental comparative study in pigs.
    Aarsaether E; Stenberg TA; Jakobsen Ø; Busund R
    Interact Cardiovasc Thorac Surg; 2009 Oct; 9(4):635-9. PubMed ID: 19628529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrograde versus antegrade delivery of cardioplegic solution in myocardial revascularization. A clinical trial in patients with three-vessel coronary artery disease who underwent myocardial revascularization with extensive use of the internal mammary artery.
    Noyez L; van Son JA; van der Werf T; Knape JT; Gimbrère J; van Asten WN; Lacquet LK; Flameng W
    J Thorac Cardiovasc Surg; 1993 May; 105(5):854-63. PubMed ID: 8487564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent.
    Bessho R; Chambers DJ
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):993-1003. PubMed ID: 11689806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potassium-induced conversion of ventricular fibrillation after aortic declamping.
    Almdahl SM; Damstuen J; Eide M; Mølstad P; Halvorsen P; Veel T
    Interact Cardiovasc Thorac Surg; 2013 Feb; 16(2):143-50. PubMed ID: 23115100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary cross-clamping and blood cardioplegia for refractory ventricular fibrillation.
    Turkoz R; Ozker E; Turkoz A
    Ann Thorac Surg; 2011 Jul; 92(1):403. PubMed ID: 21718888
    [No Abstract]   [Full Text] [Related]  

  • 7. Perfusion in cardioplegia: an experimental study.
    Addetia A; Callaghan JC
    Can J Surg; 1980 Mar; 23(2):146-50. PubMed ID: 7363175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. eComment: myocardial protection: efficacy of a novel magnesium-basedcardioplegia (RS-C) compared to St Thomas' Hospital cardioplegic solution.
    Bockeria LA; Movsesyan RR; Ryabtsev DV; Grigoryants TR
    Interact Cardiovasc Thorac Surg; 2008 Oct; 7(5):749. PubMed ID: 18801803
    [No Abstract]   [Full Text] [Related]  

  • 9. Critical importance of ensuring cardioplegic delivery with coronary stenoses.
    Becker H; Vinten-Johansen J; Buckberg GD; Follette DM; Robertson JM
    J Thorac Cardiovasc Surg; 1981 Apr; 81(4):507-15. PubMed ID: 7206757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The prolonged aortic occlusion in valvular surgery and myocardial protection].
    Nakayama Y; Aoki J; Irie H; Bando K; Sugawara E; Murakami T; Nawa S; Senoo Y; Teramoto S
    Rinsho Kyobu Geka; 1988 Apr; 8(2):174-7. PubMed ID: 9301829
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hyperpolarized cardiac arrest with ATP-sensitive potassium channel opener on myocardial protection during CPB].
    Yu T; Liu X; Yu Z; Yang S; Ye Y; Yang X; Gao Z
    Zhonghua Wai Ke Za Zhi; 2000 Dec; 38(12):931-4. PubMed ID: 11832201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance of cardiac glutathione levels after cold ischemia.
    Magovern JA; Martin LF; Pae WE; Miller CA; Answine J; Grotyohann LW; Scaduto RC
    Curr Surg; 1988; 45(1):31-3. PubMed ID: 3345683
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of (all-blood) miniplegia versus crystalloid cardioplegia in an experimental model of acute myocardial ischemia.
    Petrucci O; Wilson Vieira R; Roberto do Carmo M; Martins de Oliveira PP; Antunes N; Marcolino Braile D
    J Card Surg; 2008; 23(4):361-5. PubMed ID: 18598329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potassium-induced cardiac resetting technique for persistent ventricular tachycardia and fibrillation after aortic declamping.
    Watanabe G; Yashiki N; Tomita S; Yamaguchi S
    Ann Thorac Surg; 2011 Feb; 91(2):619-20. PubMed ID: 21256336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effects of multidose coronary artery washout during elective cardiac arrest and cardiopulmonary bypass: biochemical and hemodynamic evaluation.
    Walls JT; Nasser FN; Baron DW; Tinker JH; Harrison CE
    J Thorac Cardiovasc Surg; 1982 May; 83(5):772-8. PubMed ID: 7078246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial protection: efficacy of a novel magnesium-based cardioplegia (RS-C) compared to St Thomas' Hospital cardioplegic solution.
    Maruyama Y; Chambers DJ
    Interact Cardiovasc Thorac Surg; 2008 Oct; 7(5):745-9. PubMed ID: 18550603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relative importance of alkalinity, temperature, and the washout effect of bicarbonate-buffered, multidose cardioplegic solution.
    Lange R; Cavanaugh AC; Zierler M; Marston W; Kloner RA; Khuri SF
    Circulation; 1984 Sep; 70(3 Pt 2):I75-83. PubMed ID: 6430594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent aortic cross-clamping versus St. Thomas' Hospital cardioplegia in extensive aorta-coronary bypass grafting. A randomized clinical study.
    Flameng W; Van der Vusse GJ; De Meyere R; Borgers M; Sergeant P; Vander Meersch E; Geboers J; Suy R
    J Thorac Cardiovasc Surg; 1984 Aug; 88(2):164-73. PubMed ID: 6379305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved myocardial preservation by improved distribution of cardioplegic solutions.
    Vander Salm TJ; Okike ON; Cutler BS; Paraskos JA; Ferulo J; Daggett W
    J Thorac Cardiovasc Surg; 1982 May; 83(5):767-71. PubMed ID: 7078245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of sodium bicarbonate vials or syringes to buffer cardioplegic solutions.
    Miller LG; Gardner SN
    Am J Hosp Pharm; 1986 Jun; 43(6):1416, 1420. PubMed ID: 3014873
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.